Relative Survival, Conditional Survival, and Causes of Death in Patients with Early Gastric Cancer, with a Focus on Differences Between Cardia and Non-Cardia Cancer

Background: Many researchers believe that cardia (CGC) and non-cardia (NCGC) are two different types of tumors, having different features like incidence rate, risk factors, geographical location, and socioeconomic status. This study aims to investigate the causes of death (COD) survival rates among...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2024-12, Vol.16 (24), p.4262
Hauptverfasser: Elgenidy, Anas, Alomari, Omar, Hesn, Mohamed Marey, Khaled, Anas, Nada, Sarah A, Elsayed, Mostafa, Mahmoud, Ali, Al-kurdi, Mohammed Al-mahdi, Afifi, Ahmed M, Cholankeril, George
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 24
container_start_page 4262
container_title Cancers
container_volume 16
creator Elgenidy, Anas
Alomari, Omar
Hesn, Mohamed Marey
Khaled, Anas
Nada, Sarah A
Elsayed, Mostafa
Mahmoud, Ali
Al-kurdi, Mohammed Al-mahdi
Afifi, Ahmed M
Cholankeril, George
description Background: Many researchers believe that cardia (CGC) and non-cardia (NCGC) are two different types of tumors, having different features like incidence rate, risk factors, geographical location, and socioeconomic status. This study aims to investigate the causes of death (COD) survival rates among early gastric cancer patients with a focus on differences between CGC and NCGC. Methods: This retrospective study employed SEER*stat software (version 8.3.92) to analyze the SEER 17 plus dataset (2000–2019). Standardized mortality ratios (SMR) were computed. Relative survival and conditional survival post-diagnosis were calculated using R software (version 4.1.0) among the different subgroups. Results: Within the follow-up period, 55.4% (5381) died, predominantly within the initial year post-diagnosis. Esophageal cancer was the leading non-gastric cancer cause in CGC, while miscellaneous tumors dominated in NCGC. The 1-year and 5-year relative survival for CGC patients were 76.4% and 48.9% respectively, while for NCGC were 80.4% and 63.9%. The 3-year conditional survival after 1 year and 5e years of survival for CGC were 68.7% and 88.8%, respectively, while for NCGC were 82.2% and 93.5%, respectively. This means that the longer a person has survived after diagnosis with cancer, the greater the likelihood that person will survive for another 3 years. Conclusions: This study sheds light on the substantial impact of non-cancer COD in GC patients, underscoring the necessity of considering comorbidities in their comprehensive management and follow-up. Impact: This study contributes valuable insights for clinical decision-making and informs future research directions regarding CGC and NCGC.
doi_str_mv 10.3390/cancers16244262
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11674421</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A821761524</galeid><sourcerecordid>A821761524</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1911-2c65e9773c6d4abce293dcdb1b3a313c3906e66d8c5b6b9bac5d451b589ca29d3</originalsourceid><addsrcrecordid>eNptUk1P3DAQjapWAlHOvVrqlUBsJ876hGD5aCXUIj7O1mQ8AaOsDXayiP_DD8V0Vy2g2gfbb957Ho-nKL7xaldKXe0heKSYuBJ1LZT4VGyKqhWlUrr-_Ga_UWyndFflISVvVbtZPF_QAKNbEruc4tItYdhh8-CtG13wMLxBwVs2hylRYqFnRwTjLXOenWc1-TGxR5eBY4jDEzuFNEaHmf6a1c4qBOwk4JTFnh25vqdIOZjYIY2PRD5zo3Xw55ZfwZfr48rha_GlhyHR9nrdKq5Pjq_mP8qz36c_5wdnJXLNeSlQNaTbVqKyNXRIQkuLtuOdBMkl5kIpUsrOsOlUpzvAxtYN75qZRhDayq1if-V7P3ULspjfFWEw99EtID6ZAM68j3h3a27C0nCu2lx4nh2-rx1ieJgojeYuTDEXMhnJa93UbaP0P9YNDGSc70N2w4VLaA5mIn8Mb0SdWbv_YeVpaeEweOpdxt8J9lYCjCGlSP3fzHllXtvEfGgT-QKIiLKj</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3149547569</pqid></control><display><type>article</type><title>Relative Survival, Conditional Survival, and Causes of Death in Patients with Early Gastric Cancer, with a Focus on Differences Between Cardia and Non-Cardia Cancer</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Elgenidy, Anas ; Alomari, Omar ; Hesn, Mohamed Marey ; Khaled, Anas ; Nada, Sarah A ; Elsayed, Mostafa ; Mahmoud, Ali ; Al-kurdi, Mohammed Al-mahdi ; Afifi, Ahmed M ; Cholankeril, George</creator><creatorcontrib>Elgenidy, Anas ; Alomari, Omar ; Hesn, Mohamed Marey ; Khaled, Anas ; Nada, Sarah A ; Elsayed, Mostafa ; Mahmoud, Ali ; Al-kurdi, Mohammed Al-mahdi ; Afifi, Ahmed M ; Cholankeril, George</creatorcontrib><description>Background: Many researchers believe that cardia (CGC) and non-cardia (NCGC) are two different types of tumors, having different features like incidence rate, risk factors, geographical location, and socioeconomic status. This study aims to investigate the causes of death (COD) survival rates among early gastric cancer patients with a focus on differences between CGC and NCGC. Methods: This retrospective study employed SEER*stat software (version 8.3.92) to analyze the SEER 17 plus dataset (2000–2019). Standardized mortality ratios (SMR) were computed. Relative survival and conditional survival post-diagnosis were calculated using R software (version 4.1.0) among the different subgroups. Results: Within the follow-up period, 55.4% (5381) died, predominantly within the initial year post-diagnosis. Esophageal cancer was the leading non-gastric cancer cause in CGC, while miscellaneous tumors dominated in NCGC. The 1-year and 5-year relative survival for CGC patients were 76.4% and 48.9% respectively, while for NCGC were 80.4% and 63.9%. The 3-year conditional survival after 1 year and 5e years of survival for CGC were 68.7% and 88.8%, respectively, while for NCGC were 82.2% and 93.5%, respectively. This means that the longer a person has survived after diagnosis with cancer, the greater the likelihood that person will survive for another 3 years. Conclusions: This study sheds light on the substantial impact of non-cancer COD in GC patients, underscoring the necessity of considering comorbidities in their comprehensive management and follow-up. Impact: This study contributes valuable insights for clinical decision-making and informs future research directions regarding CGC and NCGC.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers16244262</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Age ; Analysis ; Cancer ; Cancer patients ; Care and treatment ; Datasets ; Death ; Demography ; Disease management ; Gastric cancer ; Medical prognosis ; Mortality ; Patient outcomes ; Patients ; Public health ; Software ; Stomach ; Stomach cancer ; Survival ; Survival analysis ; World health</subject><ispartof>Cancers, 2024-12, Vol.16 (24), p.4262</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1911-2c65e9773c6d4abce293dcdb1b3a313c3906e66d8c5b6b9bac5d451b589ca29d3</cites><orcidid>0000-0003-2520-570X ; 0000-0002-4532-8574 ; 0000-0002-2444-5018 ; 0000-0003-3651-4129</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11674421/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11674421/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids></links><search><creatorcontrib>Elgenidy, Anas</creatorcontrib><creatorcontrib>Alomari, Omar</creatorcontrib><creatorcontrib>Hesn, Mohamed Marey</creatorcontrib><creatorcontrib>Khaled, Anas</creatorcontrib><creatorcontrib>Nada, Sarah A</creatorcontrib><creatorcontrib>Elsayed, Mostafa</creatorcontrib><creatorcontrib>Mahmoud, Ali</creatorcontrib><creatorcontrib>Al-kurdi, Mohammed Al-mahdi</creatorcontrib><creatorcontrib>Afifi, Ahmed M</creatorcontrib><creatorcontrib>Cholankeril, George</creatorcontrib><title>Relative Survival, Conditional Survival, and Causes of Death in Patients with Early Gastric Cancer, with a Focus on Differences Between Cardia and Non-Cardia Cancer</title><title>Cancers</title><description>Background: Many researchers believe that cardia (CGC) and non-cardia (NCGC) are two different types of tumors, having different features like incidence rate, risk factors, geographical location, and socioeconomic status. This study aims to investigate the causes of death (COD) survival rates among early gastric cancer patients with a focus on differences between CGC and NCGC. Methods: This retrospective study employed SEER*stat software (version 8.3.92) to analyze the SEER 17 plus dataset (2000–2019). Standardized mortality ratios (SMR) were computed. Relative survival and conditional survival post-diagnosis were calculated using R software (version 4.1.0) among the different subgroups. Results: Within the follow-up period, 55.4% (5381) died, predominantly within the initial year post-diagnosis. Esophageal cancer was the leading non-gastric cancer cause in CGC, while miscellaneous tumors dominated in NCGC. The 1-year and 5-year relative survival for CGC patients were 76.4% and 48.9% respectively, while for NCGC were 80.4% and 63.9%. The 3-year conditional survival after 1 year and 5e years of survival for CGC were 68.7% and 88.8%, respectively, while for NCGC were 82.2% and 93.5%, respectively. This means that the longer a person has survived after diagnosis with cancer, the greater the likelihood that person will survive for another 3 years. Conclusions: This study sheds light on the substantial impact of non-cancer COD in GC patients, underscoring the necessity of considering comorbidities in their comprehensive management and follow-up. Impact: This study contributes valuable insights for clinical decision-making and informs future research directions regarding CGC and NCGC.</description><subject>Age</subject><subject>Analysis</subject><subject>Cancer</subject><subject>Cancer patients</subject><subject>Care and treatment</subject><subject>Datasets</subject><subject>Death</subject><subject>Demography</subject><subject>Disease management</subject><subject>Gastric cancer</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Public health</subject><subject>Software</subject><subject>Stomach</subject><subject>Stomach cancer</subject><subject>Survival</subject><subject>Survival analysis</subject><subject>World health</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptUk1P3DAQjapWAlHOvVrqlUBsJ876hGD5aCXUIj7O1mQ8AaOsDXayiP_DD8V0Vy2g2gfbb957Ho-nKL7xaldKXe0heKSYuBJ1LZT4VGyKqhWlUrr-_Ga_UWyndFflISVvVbtZPF_QAKNbEruc4tItYdhh8-CtG13wMLxBwVs2hylRYqFnRwTjLXOenWc1-TGxR5eBY4jDEzuFNEaHmf6a1c4qBOwk4JTFnh25vqdIOZjYIY2PRD5zo3Xw55ZfwZfr48rha_GlhyHR9nrdKq5Pjq_mP8qz36c_5wdnJXLNeSlQNaTbVqKyNXRIQkuLtuOdBMkl5kIpUsrOsOlUpzvAxtYN75qZRhDayq1if-V7P3ULspjfFWEw99EtID6ZAM68j3h3a27C0nCu2lx4nh2-rx1ieJgojeYuTDEXMhnJa93UbaP0P9YNDGSc70N2w4VLaA5mIn8Mb0SdWbv_YeVpaeEweOpdxt8J9lYCjCGlSP3fzHllXtvEfGgT-QKIiLKj</recordid><startdate>20241221</startdate><enddate>20241221</enddate><creator>Elgenidy, Anas</creator><creator>Alomari, Omar</creator><creator>Hesn, Mohamed Marey</creator><creator>Khaled, Anas</creator><creator>Nada, Sarah A</creator><creator>Elsayed, Mostafa</creator><creator>Mahmoud, Ali</creator><creator>Al-kurdi, Mohammed Al-mahdi</creator><creator>Afifi, Ahmed M</creator><creator>Cholankeril, George</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2520-570X</orcidid><orcidid>https://orcid.org/0000-0002-4532-8574</orcidid><orcidid>https://orcid.org/0000-0002-2444-5018</orcidid><orcidid>https://orcid.org/0000-0003-3651-4129</orcidid></search><sort><creationdate>20241221</creationdate><title>Relative Survival, Conditional Survival, and Causes of Death in Patients with Early Gastric Cancer, with a Focus on Differences Between Cardia and Non-Cardia Cancer</title><author>Elgenidy, Anas ; Alomari, Omar ; Hesn, Mohamed Marey ; Khaled, Anas ; Nada, Sarah A ; Elsayed, Mostafa ; Mahmoud, Ali ; Al-kurdi, Mohammed Al-mahdi ; Afifi, Ahmed M ; Cholankeril, George</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1911-2c65e9773c6d4abce293dcdb1b3a313c3906e66d8c5b6b9bac5d451b589ca29d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age</topic><topic>Analysis</topic><topic>Cancer</topic><topic>Cancer patients</topic><topic>Care and treatment</topic><topic>Datasets</topic><topic>Death</topic><topic>Demography</topic><topic>Disease management</topic><topic>Gastric cancer</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Public health</topic><topic>Software</topic><topic>Stomach</topic><topic>Stomach cancer</topic><topic>Survival</topic><topic>Survival analysis</topic><topic>World health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elgenidy, Anas</creatorcontrib><creatorcontrib>Alomari, Omar</creatorcontrib><creatorcontrib>Hesn, Mohamed Marey</creatorcontrib><creatorcontrib>Khaled, Anas</creatorcontrib><creatorcontrib>Nada, Sarah A</creatorcontrib><creatorcontrib>Elsayed, Mostafa</creatorcontrib><creatorcontrib>Mahmoud, Ali</creatorcontrib><creatorcontrib>Al-kurdi, Mohammed Al-mahdi</creatorcontrib><creatorcontrib>Afifi, Ahmed M</creatorcontrib><creatorcontrib>Cholankeril, George</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elgenidy, Anas</au><au>Alomari, Omar</au><au>Hesn, Mohamed Marey</au><au>Khaled, Anas</au><au>Nada, Sarah A</au><au>Elsayed, Mostafa</au><au>Mahmoud, Ali</au><au>Al-kurdi, Mohammed Al-mahdi</au><au>Afifi, Ahmed M</au><au>Cholankeril, George</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relative Survival, Conditional Survival, and Causes of Death in Patients with Early Gastric Cancer, with a Focus on Differences Between Cardia and Non-Cardia Cancer</atitle><jtitle>Cancers</jtitle><date>2024-12-21</date><risdate>2024</risdate><volume>16</volume><issue>24</issue><spage>4262</spage><pages>4262-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Background: Many researchers believe that cardia (CGC) and non-cardia (NCGC) are two different types of tumors, having different features like incidence rate, risk factors, geographical location, and socioeconomic status. This study aims to investigate the causes of death (COD) survival rates among early gastric cancer patients with a focus on differences between CGC and NCGC. Methods: This retrospective study employed SEER*stat software (version 8.3.92) to analyze the SEER 17 plus dataset (2000–2019). Standardized mortality ratios (SMR) were computed. Relative survival and conditional survival post-diagnosis were calculated using R software (version 4.1.0) among the different subgroups. Results: Within the follow-up period, 55.4% (5381) died, predominantly within the initial year post-diagnosis. Esophageal cancer was the leading non-gastric cancer cause in CGC, while miscellaneous tumors dominated in NCGC. The 1-year and 5-year relative survival for CGC patients were 76.4% and 48.9% respectively, while for NCGC were 80.4% and 63.9%. The 3-year conditional survival after 1 year and 5e years of survival for CGC were 68.7% and 88.8%, respectively, while for NCGC were 82.2% and 93.5%, respectively. This means that the longer a person has survived after diagnosis with cancer, the greater the likelihood that person will survive for another 3 years. Conclusions: This study sheds light on the substantial impact of non-cancer COD in GC patients, underscoring the necessity of considering comorbidities in their comprehensive management and follow-up. Impact: This study contributes valuable insights for clinical decision-making and informs future research directions regarding CGC and NCGC.</abstract><cop>Basel</cop><pub>MDPI AG</pub><doi>10.3390/cancers16244262</doi><orcidid>https://orcid.org/0000-0003-2520-570X</orcidid><orcidid>https://orcid.org/0000-0002-4532-8574</orcidid><orcidid>https://orcid.org/0000-0002-2444-5018</orcidid><orcidid>https://orcid.org/0000-0003-3651-4129</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2024-12, Vol.16 (24), p.4262
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11674421
source PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Age
Analysis
Cancer
Cancer patients
Care and treatment
Datasets
Death
Demography
Disease management
Gastric cancer
Medical prognosis
Mortality
Patient outcomes
Patients
Public health
Software
Stomach
Stomach cancer
Survival
Survival analysis
World health
title Relative Survival, Conditional Survival, and Causes of Death in Patients with Early Gastric Cancer, with a Focus on Differences Between Cardia and Non-Cardia Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T22%3A05%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relative%20Survival,%20Conditional%20Survival,%20and%20Causes%20of%20Death%20in%20Patients%20with%20Early%20Gastric%20Cancer,%20with%20a%20Focus%20on%20Differences%20Between%20Cardia%20and%20Non-Cardia%20Cancer&rft.jtitle=Cancers&rft.au=Elgenidy,%20Anas&rft.date=2024-12-21&rft.volume=16&rft.issue=24&rft.spage=4262&rft.pages=4262-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers16244262&rft_dat=%3Cgale_pubme%3EA821761524%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3149547569&rft_id=info:pmid/&rft_galeid=A821761524&rfr_iscdi=true